— Know what they know.
Not Investment Advice

XNCR NASDAQ

Xencor, Inc.
1W: -5.1% 1M: -12.3% 3M: -1.2% YTD: -24.5% 1Y: +38.5% 3Y: -57.6% 5Y: -72.2%
$11.31
+0.04 (+0.35%)
 
Weekly Expected Move ±8.8%
$9 $10 $11 $12 $13
NASDAQ · Healthcare · Biotechnology · Alpha Radar Strong Sell · Power 25 · $838.5M mcap · 54M float · 1.58% daily turnover · Short 62% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$126M +13.7% ▲
5Y CAGR: +0.5%
Gross Profit
$115M +4.1% ▲
Operating Income
-$178M +0.5% ▲
Net Income
-$92M +60.5% ▲
EPS (Diluted)
$-1.24 +65.4% ▲
EBITDA
-$47M +74.8% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$275M$165M$175M$110M$126M
YoY Growth+124.2%-40.2%+2.3%-34.4%+13.7%
Cost of Revenue$0$0$0$0$11M
Gross Profit$275M$165M$175M$110M$115M
Gross Margin100.0%100.0%100.0%100.0%91.6%
R&D Expenses$193M$200M$254M$228M$239M
SG&A Expenses$39M$47M$53M$61M$64M
Operating Expenses$231M$247M$307M$289M$293M
Operating Income$44M-$82M-$132M-$178M-$178M
Operating Margin15.9%-50.1%-75.8%-161.5%-141.4%
Interest Expense$0$0$0$37M$32M
Income Before Tax$83M-$55M-$120M-$235M-$89M
Tax Expense$0$673K$14M$2M$3M
Net Income$83M-$55M-$133M-$233M-$92M
Net Margin30.0%-33.5%-76.2%-210.5%-73.2%
EPS (Diluted)$1.37$-0.93$-2.08$-3.58$-1.24
EBITDA$90M-$46M-$102M-$186M-$47M
Shares Outstanding60M60M61M65M74M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms